Table 4.
Association between respondents demographic and knowledge of adverse event reactions.
| Variables | Encountered any adverse event during the administration of PPIs |
P value | |
|---|---|---|---|
| Yes (%) | No (%) | ||
| Age group | |||
| 25–35 | 255 (24) | 808 (76.0) | 0.083* |
| 36–45 | 24 (16.9) | 118 (83.1) | |
| 46–55 | 5 (41.7) | 7 (58.3) | |
| More than 55 years | – | 2 (100) | |
| Experience in CP Saudi Arabia | 0.025 | ||
| Less than 6 months | 31 (36.0) | 55 (64.0) | |
| More than 6 months | 21 (20.8) | 80 (79.2) | |
| More than one year | 38 (25.3) | 112 (74.7) | |
| More than 2 years | 194 (22.0) | 687 (78.0) | |
| Years of practice | |||
| Less than 10 years | 231 (25) | 694 (75) | 0.13* |
| 11–20 | 50 (18) | 228 (82.0) | |
| 21–30 | 2 (20) | 8 (80.0) | |
| 31–40 | 1 (20) | 4 (80) | |
| More than 40 years | – | 1 (100) | |
| Country of graduation | |||
| Egypt | 253 (22.3) | 881 (77.7) | |
| Yemen | 21 (45.7) | 25 (54.3) | 0.001 |
| Saudi Arabia | 8 (50) | 8 (50) | * |
| Sudan | – | 8 (100) | |
| Others | 2 (13.3) | 13 (86.7) | |
*
Fisher’s exact test.